Published in Int J Cancer on May 10, 2003
Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker. Neoplasia (2004) 1.03
Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad. PLoS One (2010) 1.01
Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: role of molecular charge, central metal and hydroxyl radical production. Cancer Lett (2009) 0.99
Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation. Radiat Res (2004) 0.97
Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate. Radiat Res (2010) 0.95
Multimodal bacteriochlorophyll theranostic agent. Theranostics (2011) 0.95
Regioselective 15-bromination and functionalization of a stable synthetic bacteriochlorin. J Org Chem (2007) 0.94
Focal therapy in the management of prostate cancer: an emerging approach for localized prostate cancer. Adv Urol (2012) 0.91
Novel photosensitizers trigger rapid death of malignant human cells and rodent tumor transplants via lipid photodamage and membrane permeabilization. PLoS One (2010) 0.86
Bypass of tumor drug resistance by antivascular therapy. Neoplasia (2004) 0.86
Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells. Eur Biophys J (2007) 0.85
Focal treatment of prostate cancer with vascular-targeted photodynamic therapy. ScientificWorldJournal (2008) 0.82
Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors. Breast Cancer Res (2010) 0.82
Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure. World J Urol (2015) 0.81
Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment. Br J Cancer (2003) 0.80
Fluorescent molecular imaging and dosimetry tools in photodynamic therapy. Methods Mol Biol (2010) 0.79
Animal models for photodynamic therapy (PDT). Biosci Rep (2015) 0.79
Detection of light images by simple tissues as visualized by photosensitized magnetic resonance imaging. PLoS One (2007) 0.78
TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer. World J Urol (2015) 0.77
Chemophototherapy: An Emerging Treatment Option for Solid Tumors. Adv Sci (Weinh) (2016) 0.77
Recent advances in imaging-guided interventions for prostate cancers. Cancer Lett (2014) 0.76
The tumor as an organ: comprehensive spatial and temporal modeling of the tumor and its microenvironment. BMC Bioinformatics (2016) 0.75
Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insight. World J Methodol (2016) 0.75
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer. Clin Cancer Res (2006) 7.09
Randomized trial of stone fragment active retrieval versus spontaneous passage during holmium laser lithotripsy for ureteral stones. J Urol (2010) 3.33
Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol (2004) 3.09
The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J (2002) 2.99
Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc Natl Acad Sci U S A (2003) 2.85
The diagnosis and management of postoperative chylous ascites. J Urol (2002) 2.59
TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer. BJU Int (2013) 2.44
A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity. J Immunol (2009) 2.43
Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity (2013) 2.08
Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity (2008) 2.04
Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J (2004) 1.90
Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes. J Clin Invest (2004) 1.70
A novel day blindness in sheep: epidemiological, behavioural, electrophysiological and histopathological studies. Vet J (2009) 1.69
Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J Exp Med (2009) 1.69
Redirected tumor-specific allogeneic T cells for universal treatment of cancer. Blood (2011) 1.69
Testosterone and prostate cancer: revisiting old paradigms. Eur Urol (2009) 1.65
Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice. Gastroenterology (2008) 1.61
Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. J Exp Med (2010) 1.60
The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. J Am Chem Soc (2005) 1.47
Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. Nat Med (2003) 1.45
Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation. Blood (2004) 1.43
A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy. J Biol Chem (2010) 1.41
Water diffusion in the different microenvironments of breast cancer. NMR Biomed (2004) 1.40
Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res (2002) 1.40
Single-incision transureteral laparoscopic nephrectomy: a proof of concept. J Endourol (2009) 1.39
Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Phys Med Biol (2009) 1.39
Short report: concurrent Rocky Mountain spotted fever in a dog and its owner. Am J Trop Med Hyg (2002) 1.28
The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells. Nat Cell Biol (2012) 1.27
Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT). Crit Rev Oncol Hematol (2008) 1.26
Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin. J Phys Chem A (2009) 1.26
Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers. Photochem Photobiol (2002) 1.23
Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses. BJU Int (2008) 1.23
Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins. Photochem Photobiol (2005) 1.22
WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model. Photochem Photobiol (2005) 1.21
Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn (2010) 1.19
Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. Cancer Res (2006) 1.18
Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino Acid Peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion. Cancer Res (2004) 1.15
Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity. J Biol Chem (2004) 1.14
Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain. J Biol Chem (2013) 1.11
Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery. Int J Cancer (2002) 1.10
Runx3 knockouts and stomach cancer. EMBO Rep (2003) 1.09
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease. J Pharmacol Exp Ther (2006) 1.08
Spanning high-dimensional expression space using ribosome-binding site combinatorics. Nucleic Acids Res (2013) 1.08
Growth inhibition of prostate cancer xenografts by halofuginone. Prostate (2002) 1.07
Scrotal epidermal inclusion cyst clinically mimicking polyorchidism in a child: ultrasonic characteristics. Pediatr Radiol (2003) 1.06
Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations. Expert Rev Anticancer Ther (2009) 1.05
Torsion of the cryptorchid testis--can it be salvaged? J Urol (2006) 1.03
Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker. Neoplasia (2004) 1.03
Development of adoptive cell therapy for cancer: a clinical perspective. Hum Gene Ther (2010) 1.03
Laparoscopic partial nephrectomy for central tumors: analysis of perioperative outcomes and complications. J Urol (2008) 1.03
Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad. PLoS One (2010) 1.01
Immuno-gene therapy of established prostate tumors using chimeric receptor-redirected human lymphocytes. Cancer Res (2003) 1.01
From chloroplasts to photosystems: in situ scanning force microscopy on intact thylakoid membranes. EMBO J (2002) 1.00
Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels. J Biol Chem (2011) 0.99
Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential. Nat Med (2011) 0.99
Laparoscopic surgery for renal stones: is it indicated in the modern endourology era? Int Braz J Urol (2009) 0.98
Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor. Gastroenterology (2009) 0.97
Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts. Prostate (2008) 0.97
Manipulation of redox signaling in mammalian cells enabled by controlled photogeneration of reactive oxygen species. J Cell Sci (2005) 0.97
Altered mode of allelic replication accompanied by aneuploidy in peripheral blood lymphocytes of prostate cancer patients. Int J Cancer (2004) 0.97
Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis. Cell Microbiol (2007) 0.97
Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis. BMC Dev Biol (2007) 0.95
Absence of Runx3 expression in normal gastrointestinal epithelium calls into question its tumour suppressor function. EMBO Mol Med (2011) 0.95
Redirected T cells that target pancreatic adenocarcinoma antigens eliminate tumors and metastases in mice. Gastroenterology (2012) 0.94
Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteins. J Biol Chem (2002) 0.94
Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunol Immunother (2008) 0.93
Identification of extracellular signal-regulated kinase 1/2 and p38 MAPK as regulators of human sperm motility and acrosome reaction and as predictors of poor spermatozoan quality. J Biol Chem (2008) 0.93
Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect. Mol Cancer Ther (2007) 0.93
Phylogenesis and regulated expression of the RUNT domain transcription factors RUNX1 and RUNX3. Blood Cells Mol Dis (2003) 0.93
Ethanol and polyvinyl alcohol mixture for transcatheter embolization of renal angiomyolipoma. AJR Am J Roentgenol (2006) 0.93
Protein flexibility acclimatizes photosynthetic energy conversion to the ambient temperature. Nature (2006) 0.92
Chylous ascites after radical nephrectomy and inferior vena cava thrombectomy. Successful conservative management with somatostatin analogue. Eur Urol (2002) 0.92
Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer. Expert Opin Biol Ther (2014) 0.92
Local oxidative stress expansion through endothelial cells--a key role for gap junction intercellular communication. PLoS One (2012) 0.90
Retrograde intra-renal surgery for stone extraction. Scand J Urol Nephrol (2007) 0.90
Runx3 regulates dendritic epidermal T cell development. Dev Biol (2006) 0.89